Transplantation, AutologousBone Marrow TransplantationBone MarrowStem Cell TransplantationHematopoietic Stem Cell TransplantationBone Marrow CellsBone Marrow PurgingCombined Modality TherapyStem CellsMelphalanCarmustineCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsMultiple MyelomaLymphoma, Non-HodgkinHematopoietic Stem CellsRemission InductionEtoposideHodgkin DiseaseWhole-Body IrradiationBone and BonesTreatment OutcomeThiotepaSalvage TherapyCytarabineTransplantation ConditioningVincristinePeripheral Blood Stem Cell TransplantationRecurrenceHematopoietic Stem Cell MobilizationDisease-Free SurvivalTransplantation, HomologousBusulfanInjectionsSurvival RateBone Marrow DiseasesSurvival AnalysisPodophyllotoxinAntigens, CD34Colony-Forming Units AssayHematopoiesisDoxorubicinLeukemia, Myeloid, AcuteCell DifferentiationTime FactorsMesenchymal Stem Cell TransplantationLymphomaLymphoma, FollicularGranulocyte Colony-Stimulating FactorAutograftsFollow-Up StudiesPrognosisEmbryonic Stem CellsDexamethasoneBlood Transfusion, AutologousAdult Stem CellsLeukemia, MyeloidIfosfamidePrednisoneAmyloidosisAntineoplastic Agents, AlkylatingMyeloablative AgonistsCells, CulturedRetrospective StudiesMitoxantroneBone RemodelingLymphoma, Mantle-CellGraft SurvivalBone TransplantationMesenchymal Stromal CellsBone Marrow ExaminationBoronic AcidsPyrazinesDrug EvaluationBone Marrow NeoplasmsCell SeparationAntibodies, MonoclonalNeuroblastomaLymphoma, B-CellThalidomidePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemiaGraft vs Host DiseasePluripotent Stem CellsFlow CytometryCarboplatinLymphoma, T-Cell, PeripheralNeoplasm, ResidualAntibodies, Monoclonal, Murine-DerivedAntineoplastic AgentsStem Cell NichePlatelet CountMyelodysplastic SyndromesProspective StudiesLeukocyte CountNeutropeniaBone DensityMice, Inbred C57BLActuarial AnalysisLeukapheresis